Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world’s first approved T cell receptor (TCR) therapy
Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world’s first approved T cell receptor (TCR) therapy. The company aims to radically improve outcomes for patients with cancer, infectious diseases, and autoimmune diseases through transformative immunomodulating medicines.